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ABSTRACT 
Introduction: Cervical cancer is a malignancy in women with the number one mortality and 
number two morbidity in the world. As many as 77% cases are found in developing coun-
tries, including Indonesia. Although deadly, screening programs can reduce the morbidity 
and mortality of this malignancy. Visual Inspection with Acetic Acid (VIA) is a cervical 
premalignancy screening method used in primary health care in Indonesia. Smoking is one of 
risk factor associated with cervical cancer and data from GATS, Infodatin 2015 & Riskedas 
2013 states that the number of passive smokers in Indonesia is high.  
Aim: The objective of this research is to look for the correlation between history of passive 
smoker and positive VIA  
Methods: This research is a retrospective cross sectional analytic study. The data used in this 
study is the medical records of VIA screening visitors in 2016. The data were extracted on 
the research questionnaire. Data processing is done by using SPSS Statistics 23 For Win-
dows computer software. The test is Chi Square correlation test and calculation of Prevalence 
Ratio (PR).  
Result: 55 women (24.7%) had a history of passive smoking (daily cigarette smoke expo-
sure), and 168 women (75.3%) had no daily cigarette smoke. 21 women (9.4%) received pos-
itive results, and 202 women (90.6%) received negative IVA. In the Pearson Chi-Square sec-
tion, the Asymptotic Significance (2-sided) yielded results at 0.042 (p <0.05) 
Conclusion: There is a relationship between passive smokers with positive VIA results. 
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INTRODUCTION 
Women's reproductive health is 
one of the country's references with re-
gard to the optimal degree of health1. 
Many factors are affecting a woman's 
gynecological health, especially regard-
ing infections and malignancy of the re-
productive organs. These cause factors 
included women's low knowledge about 
reproductive health and health facilities 
that are not evenly distributed2. It can 
lead to a high prevalence of cervical 
cancer, especially in Indonesia. 
Currently, cervical cancer is a ma-
lignancy in women with a mortality rate 
of number one and number two morbidi-
ty in the world. Every year 500,000 new 
cases of cervical cancer are found, and 
more than 250,000 deaths from cervical 
cancer3. Among cervical cancer cases in 
the world, 77% of cases are found in de-
veloping countries2. Data from Pusdatin 
(Data and Information Center) estimates 
98,692 cases of cervical cancer in Indo-
nesia. It is estimated that the most com-
mon case of cervical cancer is in the 
province of East Java, which is 21,313 
cases4. 
Besides the high incidence rate, 
another problem is that almost 70% of 
cases in the hospital, the patients are al-
ready in an advanced state (more than 
IIB). At this stage, even the effective-
ness of complete treatment still does not 
produce satisfactory results and still re-
sults in high mortality3. It should also be 
remembered that financing for handling 
cancer at an advanced stage is relatively 
more expensive than the cost of treating 
cancer at an early stage5. 
Although deadly, effective early 
detection or screening programs can re-
duce the morbidity and mortality of the-
se malignancies6. The screening tests 
used include human papillomavirus 
(HPV) tests, cytology (Pap smears), and 
Visual Inspection with Acetic Acid 
(VIA)7. 
In developed countries, routine 
screening with the Pap smear method 
can reduce the risk of invasive cervical 
cancer, namely through early detection 
of praganas. The situation is different 
from the situation in developing coun-
tries. The number of women screened 
using the Pap smear method in develop-
ing countries is still low. The screening 
rate is low because women's knowledge 
of reproductive health is still lacking 2. 
Rare Pap smear screening methods are 
also caused by the fact that there are still 
very few trained and professional staff 
with the skills to implement the program 
effectively. In practice in developing 
countries, histopathological services are 
also limited to large hospitals and labor-
atories in urban areas. These are obsta-
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cles to the implementation of an effec-
tive screening program6. 
To overcome this problem, efforts 
can be made to increase the promotion 
of early detection of cervical cancer. 
Another effort needed is the implemen-
tation of an early cervical cancer detec-
tion program nationally. Although Pap 
smears are an ideal screening method, 
the use of these methods as a national 
screening program is still a barrier in 
developing countries2. 
It is necessary to solve the problem 
regarding the implementation of cervical 
cancer screening programs in Indonesia. 
The solution to this condition is the im-
plementation of cervical praganas 
screening with an alternative method. 
Now, cervical cancer screening with 
IVA method has been used as an alterna-
tive method of Pap smear method in are-
as with limited facilities8. Various stud-
ies have shown that IVA is an appropri-
ate screening method applied in primary 
health care in remote areas8,9. This is 
based on the advantages of IVA is a 
method of early detection of cervical 
cancer that is non-invasive and offers 
efficiency and effectiveness (simple 
method, immediate results are obtained) 
at an affordable price6. 
According to the Book of Obstet-
rics and Social Gynecology, cervical 
cancer is found in a population of wom-
en with a history of early sexual rela-
tions, a history of multipartner, as well 
as in areas with a high smoking preva-
lence1. According to the GATS (Global 
Adult Tobacco Survey), Indonesia is a 
country with the highest prevalence of 
male smokers. GATS data also shows 
that Indonesia is the country with the 
highest prevalence of passive smokers at 
home (78%) and the second highest 
prevalence of passive smokers in public 
places (59%)10. This can lead to high 
cervical cancer rates in Indonesia. 	
 METHODS 
This research is an observational 
study. The approach used is retrospec-
tive. The association analytic study was 
carried out with a cross-sectional re-
search design. The data recorded is sec-
ondary data in the form of IVA screen-
ing medical records for the period Janu-
ary-December 2016. 
Data were collected at the KIA 
unit of Puskesmas Wonoayu. The 
implementation of medical record data 
recording in two stages (due to a large 
number of samples in total sampling), 
namely on October 19, 2017, and 
October 26, 2017. The process of 
recording samples from medical records 
is done by recording data from medical 
records on the research questionnaire 
sheet. 
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The extracted data was compiled 
based on a history of daily cigarette 
smoke exposure (the dependent variable) 
and IVA screening results (independent 
variable) in the SPSS application. The 
distribution of the two variables will be 
presented in tabular form. Analysis of 
the relationship between the two 
variables was carried out using Chi-
Square analysis. In the next step, the 
data is presented in a 2x2 cross-
tabulation table, and Prevalence Ratio 
(RP) is calculated to find out how the 
two variables relate. 
	
RESULT 
The characteristics of the study 
sample from the 2016 IVA screening 
medical record are illustrated in the 
following table. 
Table 1 Characteristics of the study sample 
based on a history of passive smoking 
 Freq % 
Valid 
% 
Cumulative 
% 
Valid 55 24,7 24,7 24,7 
Not 
Valid 
168 75,3 75,3 100 
Total 223 100 100  
 
Table 1 above shows: 55 women 
(24.7%) had a history of passive 
smoking (daily cigarette smoke 
exposure), and 168 women (75.3%) had 
no daily cigarette smoke. 
 
Table	2	Characteristics	of	study	samples	based	on	Positive	IVA	results.	
 Freq % 
Valid 
% 
Cumulative 
% 
Valid 55 24,7 24,4 24,7 
Not 
Valid 
168 75,3 75,3 100 
Total 223 100 100  
Table 2 above shows: 21 women 
(9.4%) received positive results, and 202 
women (90.6%) received negative IVA 
results. 
The results of the correlation test 
of the two variables are illustrated in the 
following table. 
Table 3 Chi-Square correlation test results 
 Value df 
AS 
two-
sided 
ES 
two-
sided 
ES 
one-
sided 
Pearson 
Chi-Square 
4,130a 1 0,042   
Continuity 
Correc-
tionb 
3,120 1 0,077   
Likelihood 
Ratio 
 1 0,054   
Fisher's 
Exact Test 
   0,060 0,043 
Linear-by-
Linear 
Associa-
tion 
4,111 1 0,043   
n of Valid 
Cases 
223     
 
a = Zero cells (0,0%) have expected count less than 5.  
The minimum expected count is 5,18. 
b = Computed only for a 2x2 tables 
AS =  Asymptotic Significance 
ES =  Exact Sig. 
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In the Pearson Chi-Square section, 
the Asymptotic Significance (2-sided) 
yielded results at 0.042 (p <0.05). These 
results indicate that there is a 
relationship between passive smoking 
with positive IVA results. The following 
table crosses the tabulation of the two 
variables and calculation of the value of 
RP (Prevalence Ratio). 
 
Table 4. Cross Tabulation 
 IVA Result 
Total 
 Positive Negative 
Exposed 9 46 55 
Not 
Exposed 
12 156 168 
Total 21 202 223 
 
 𝑅𝑃 = 𝑎𝑎 + 𝑏 𝑐𝑐 + 𝑑	𝑅𝑃 = 99+ 46 1212+ 156	𝑅𝑃 = 2.29 
 
Where: 
a =  subjects with risk factors 
experiencing effects (exposure to 
secondhand smoke, Positive IVA) 
b = subjects with no risk factors (no 
exposure to cigarette smoke, 
negative IVA) 
c = subjects without risk factors having 
an impact (not exposed to cigarette 
smoke, Positive IVA) 
d = subjects without risk factors that had 
no effect (not exposed to cigarette 
smoke, negative IVA) 
Interpretation: The value of the 
Prevalence Ratio obtained is 2.29 (> 1). 
Therefore, the variable passive smoking 
is a risk factor for the team's Positive 
IVA results. 
 
DISCUSSION 
According to Infodatin data 
published in 2015, in 2013, there were 
24.3% of Indonesian people who were 
active smokers every day. Infodatin data 
reveal that the prevalence of active 
smokers is 16 times higher in men than 
women. According to Tobacco Facts 
Books, 2.7% of women have a history of 
active smokers. Among these women, as 
many as 1.1% of women smoke every 
day, 0.8% of women sometimes smoke, 
and another 0.8% are former smokers 11. 
Riskesdas 2013 data shows: the 
number of daily active smokers in 
villages is higher than in cities. The 
percentage of active smokers in villages 
that smoked in their homes, with family 
members in the vicinity, was also higher 
in villages compared to cities (87.65% 
compared to 73.01%). Data from the 
Book of Tobacco Interest Facts and Its 
Problems in Indonesia (2012) states that 
the number of female passive smokers is 
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two times greater than the number of 
male passive smokers12. 
Of the 223 study samples, 55 
women (24.7%) received daily exposure 
to cigarette smoke; of these, 21 women 
(42%) showed positive IVA results. 
Statistical analysis showed that the 
value of p <0.05 (that is, the value of p = 
0.042). This indicates that there is a 
relationship between the history of 
passive smoking with the results of IVA 
(Acetic Acid Visual Inspection) Positive 
at the Wonoayu Public Health Center at 
Sidoarjo. 
There are various risk factors 
associated with cervical cancer; for 
example, the history of early coitus, 
multi-partner, multiparity, smoking, and 
exposure to cigarette smoke. Among 
these risk factors, cigarette smoke 
exposure is a risk factor of concern in 
Indonesia. This is because the number of 
women exposed to cigarette smoke 
every day is still very high (GATS, 
Infodatin, Pusdatin, Riskesdas, and 
Tobacco Facts). Many health problems 
arise due to exposure to cigarette smoke, 
such as low birth weight, cardiovascular 
disease, airways, and malignancy13,14,15. 
The Tobacco Facts Flower Book 
states that cervical cancer is a woman's 
tobacco-related malignancy with the 
highest morbidity, mortality, and 
disability rates. The discussion in the 
next section noted that the number of 
active smokers in women is low. 
Therefore, it can be said that high 
cervical cancer rates, as the highest 
female malignancy associated with 
tobacco, are caused by daily exposure to 
cigarette smoke16. 
In this study, samples with 
confounding variables (early coitus, 
multi-partner, multiparity, and active 
smoking) were excluded. It aims to see 
cigarette smoke exposure as an 
independent risk factor. 
The results of this study indicate 
there is a relationship between daily 
cigarette smoke exposure with positive 
IVA results. These results are in line 
with research results published in the 
Asian Pacific Journal of Cancer 
Prevention, the Institute of Cytology and 
Preventive Oncology, WHO, the 
American College of Obstetricians and 
Gynecologists, and the ISRN Obstetrics 
and Gynecology which states the 
existence of a relationship between a 
history of cigarette smoke exposure with 
cervical cancer17,18,19. 
The pathogenesis of cervical 
cancer due to exposure to passive 
cigarette smoke has been investigated by 
Cancer Epidemiology Biomarkers & 
Prevention and WHO. Cigarette smoke 
inhaled enters the circulatory system 
through diffusion in the pulmonary 
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alveoli capillaries and is distributed to 
various locations in the body. Cancer 
Epidemiology Research Biomarkers & 
Prevention states: nicotine and cotinine 
are found in the cervical mucus of active 
and passive smokers. These findings 
prove that compounds in cigarette smoke 
can reach the cervix. Both passive 
cigarette metabolites such as Benzo (a) 
pyrene diol epoxide and polycyclic 
aromatic hydrocarbons heterocyclic 
amine play a role in the pathogenesis of 
cervical cancer20,21. Both metabolites 
play a role in the process of cervical 
epithelial cellular immunosuppression 
(immuno-suppression of cervical 
Langerhans cells)22,23. The 
immunosuppression process causes 
persistent HPV infection in the cervix. 
These persistent infections can cause 
changes in cervical epithelial cells 
leading to malignancy. Another opinion 
put forward by WHO states that the 
metabolites of polycyclic aromatic 
hydrocarbons heterocyclic amine cause 
mutations of cervical epithelial cells 
leading to malignancy24,25,26. 
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